News

IT Pharma news

Pamplona, Navarra – In a joint effort to promote and retain local talent, IT Pharma, a Navarra-based manufacturer of medical devices and cosmetics for aesthetic medicine, and Foro Europeo, a renowned business school in Navarra,...

Last Saturday we held a theoretical and practical training session at our facilities in Pamplona with some of the doctors from the London Clinic....

Through its distributors in Pakistan, the Pakistani company Currax, the aesthetic medicine laboratory from Navarra attended the 3rd International Aesthetic Conference held at the Marriott Islamabad, Pakistan, which brought together leaders and experts in aesthetic...

A new trend has started in the beauty world regarding the glow effect on the skin. But what does it really mean to have glow skin?...

Acne, influenced by various hormonal changes such as pregnancies, starting or stopping birth control pills, or menopause, can persist beyond the age of 30 in some individuals. This common skin condition can be bothersome, although...

In an interview with its creator, Dr. Kwon talks about the benefits and virtues of PDO microspheres and their significant advantages over other collagen inducers in aesthetic medicine, especially highlighting the ability to generate collagen...
Exercise and nutrition are essential requirements for good health and radiant, glowing skin. But there are situations in which we find ourselves with localized stubborn fat that becomes a challenge to eliminate....
IT Pharma Bulgaria participated in the Dermatocosmetic Symposium Beauty Woman IX, which took place on March 30-31 in Sofia....

IT Pharma, in collaboration with a distinguished group of aesthetic medicine professionals, has contributed to the editing of this manual on the adverse effects of fillers, coordinated and written by Dr. Paloma Tejero and Dr....

We are excited to announce the launch of our latest innovation in our portfolio: the new line of Injectable Crosslinked Hyaluronic Acid HARMONIE 2.0! A more attractive and comprehensive line of our crosslinked products, and...